XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Assets:    
Cash and cash equivalents $ 13,807 $ 12,945
Investments 3,080 2,778
Accounts receivable, net 29,546 27,276
Inventories 17,291 19,090
Assets held for sale 620 908
Other current assets 3,412 2,636
Total current assets 67,756 65,633
Long-term investments 22,114 21,096
Property and equipment, net 13,001 12,873
Operating lease right-of-use assets 17,703 17,872
Goodwill 91,260 78,150
Intangible assets, net 30,118 24,803
Separate accounts assets 3,267 3,228
Other assets 4,852 4,620
Total assets 250,071 228,275
Liabilities:    
Accounts payable 13,367 14,838
Pharmacy claims and discounts payable 20,417 19,423
Health care costs payable 11,998 10,142
Policyholders’ funds 1,411 1,500
Accrued expenses 22,831 18,745
Other insurance liabilities 4,866 1,089
Current portion of operating lease liabilities 1,706 1,678
Short-term debt 1,000 0
Current portion of long-term debt 1,402 1,778
Liabilities held for sale 208 228
Total current liabilities 79,206 69,421
Long-term operating lease liabilities 16,609 16,800
Long-term debt 61,419 50,476
Deferred income taxes 4,588 4,016
Separate accounts liabilities 3,267 3,228
Other long-term insurance liabilities 5,659 5,835
Other long-term liabilities 6,321 6,730
Total liabilities 177,069 156,506
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,764 shares issued and 1,282 shares outstanding at June 30, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus 48,649 48,193
Treasury stock, at cost: 482 shares at June 30, 2023 and 458 shares at December 31, 2022 (33,933) (31,858)
Retained earnings 58,868 56,398
Accumulated other comprehensive loss (858) (1,264)
Total CVS Health shareholders’ equity 72,726 71,469
Noncontrolling interests 276 300
Total shareholders’ equity 73,002 71,769
Total liabilities and shareholders’ equity $ 250,071 $ 228,275